2010
DOI: 10.1007/s00280-010-1355-4
|View full text |Cite
|
Sign up to set email alerts
|

In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
46
0

Year Published

2010
2010
2016
2016

Publication Types

Select...
6
1
1

Relationship

3
5

Authors

Journals

citations
Cited by 47 publications
(47 citation statements)
references
References 43 publications
1
46
0
Order By: Relevance
“…However, this interaction requires further investigation before implementation. Gravett et al [112] have reported antagonism between artemisinin and oxaliplatin on colon cancer cells, and Riganti et al [165] reported that artemisinin induced doxorubicin resistance in human colon cancer cells. On the other hand, artemisinin compounds have been shown to be toxic towards various multiple drug-resistant cancer cell lines [131,[166][167][168].…”
Section: Discussionmentioning
confidence: 97%
See 2 more Smart Citations
“…However, this interaction requires further investigation before implementation. Gravett et al [112] have reported antagonism between artemisinin and oxaliplatin on colon cancer cells, and Riganti et al [165] reported that artemisinin induced doxorubicin resistance in human colon cancer cells. On the other hand, artemisinin compounds have been shown to be toxic towards various multiple drug-resistant cancer cell lines [131,[166][167][168].…”
Section: Discussionmentioning
confidence: 97%
“…Combination of these compounds with traditional chemotherapeutic agents may achieve a synergistic effect with fewer side effects. Synergism has been reported between artesunate with fotemustine and dacarbazine on human uveal melanoma [99]; artesunate and epidermal growth factor receptor tyrosine kinase inhibitor on glioblastoma multiforme cells [162]; artesunate and vinovelbine and cisplatin on human non-small cell lung cancer [101]; dihydroartemisinin and temozolomide on rat C6 glioma cells [163]; artemisinin and dihydroartemisinin with gemcitabine on hapatoma xenograph in mice [8]; Dihydroartemisinin and carboplatin on ovarian cancer cells in vitro and vivo [6]; dihydroartemisinin and gemcitabine on pancreatic cancer xenograft in mice [97]; dihydroartemisinin with cisplatin and cyclophosphamide on lung cancer xenographs in mice [96]; artesuante with lenalidomide on A549 lung cancer cells and MCF7 breast cancer cells (not on HCT116 colon cancer cells); artemisone with gemcitabine, oxaliplatin and thalidomide on human colon and breast cancer cells [112]; and artesunate and the anti-CD20 antibody rituximab [164]. However, this interaction requires further investigation before implementation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Importantly, artemisone is cytotoxic towards cancer cell lines, where in combination with known anticancer agents, is consistently more active than current artemisinins. Activity alone (IC 50 ) against the MJT3 and KM melanoma cell lines were 30 and 6.4 M, making artemisone over an order of magnitude more active than artemisinin [18]. It further appears that combinations of artemisone with known anticancer drugs have a greater potentiating effect on the action of each drug than does artemisinin.…”
Section: Introductionmentioning
confidence: 97%
“…Moreover, artesunate exhibits anti-angiogenic effect in human ovarian cancer through inhibiting the VEGF receptor KDR/flk-1 expression . Finally, recent study shows that the old member of the artemisinin derivates artemisone also exhibits significant anti-tumor effect (Gravett et al, 2010). These extensive studies reveal the potential of compounds from Herba artemisiae annuae for anti-cancer therapy in clinical practice.…”
Section: Herba Artemisiae Annuae (Qinghao In Chinese)mentioning
confidence: 99%